CNS Response is a life-sciences data company focused on the commercialization of a patented biomarker system that guides psychiatrists and other physicians to determine proper treatments for patients with behavioral (mental or addictive) disorders. Likewise CNSO assists pharmaceutical companies understanding of their psychotropic medications.